Evidence map›Paper›PMID 42071848›Full record

ArticleMedicine2026

Intraoperative use of the EndoScell scanner to assist in the surgical resection of papillary thyroid carcinoma: A case report.

Yaqian Liu, Zhuoyang Zhou, Lixiao Ma, Zeyu Zhang, Fenghua Zhang

Abstract readCase Reports
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yaqian LiuDepartment of Clinical Medicine and Surgery, Hebei Medical University, Shijiazhuang, China.
Zhuoyang ZhouDepartment of Clinical Medicine and Surgery, North China University of Science and Technology, Tangshan, China.
Lixiao MaDepartment of Clinical Medicine and Surgery, Hebei Medical University, Shijiazhuang, China.
Zeyu ZhangDepartment of Clinical Medicine and Surgery, Hebei North University, Zhangjiakou, China.
Fenghua ZhangDepartment of Gland Surgery, Hebei Provincial People's Hospital, Shijiazhuang, China.ORCID 0009-0005-8761-6936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleAccurate resection of papillary thyroid carcinoma (PTC) is key to prognosis, but frozen section has sampling and time limitations. PATIENT CONCERNS: A 50-year-old female was diagnosed with suspected PTC and underwent surgical treatment. DIAGNOSES: Intraoperative EndoCell detected residual atypical cells, and postoperative pathology confirmed bilateral PTC.

interventionsThe patient underwent a total thyroidectomy, with intraoperative EndoCell (real-time cellular imaging) used with nanocarbon/indocyanine green to assess margins and preserve parathyroids. OUTCOMES: EndoCell guided complete resection of residual tumor, with parathyroids preserved and no severe postoperative complications. LESSONS: EndoCell overcomes the limitations of frozen section, enhancing PTC surgical precision and safety when combined with complementary imaging.

Indexed as

Carcinoma, PapillaryThyroid Cancer, PapillaryThyroidectomyThyroid NeoplasmsFemaleFrozen SectionsHumansMiddle Agedcellular-level technologyEndoScellfrozen sectionpapillary thyroid carcinomathyroid nodules

Identifiers

PMID42071848
PMCPMC13124358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.